Ascletis Pharma Stock Market Value
| ASCLF Stock | USD 1.76 0.01 0.56% |
| Symbol | Ascletis |
Ascletis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ascletis Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ascletis Pharma.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Ascletis Pharma on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Ascletis Pharma or generate 0.0% return on investment in Ascletis Pharma over 90 days. Ascletis Pharma is related to or competes with SanBio Company, CStone Pharmaceuticals, Pharming Group, Idorsia, SSY Group, Biogaia AB, and Tobii Dynavox. Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale... More
Ascletis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ascletis Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ascletis Pharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.7 | |||
| Information Ratio | 0.1072 | |||
| Maximum Drawdown | 52.45 | |||
| Value At Risk | (4.69) | |||
| Potential Upside | 12.11 |
Ascletis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ascletis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ascletis Pharma's standard deviation. In reality, there are many statistical measures that can use Ascletis Pharma historical prices to predict the future Ascletis Pharma's volatility.| Risk Adjusted Performance | 0.0961 | |||
| Jensen Alpha | 0.6702 | |||
| Total Risk Alpha | 0.1907 | |||
| Sortino Ratio | 0.0664 | |||
| Treynor Ratio | 0.4787 |
Ascletis Pharma January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0961 | |||
| Market Risk Adjusted Performance | 0.4887 | |||
| Mean Deviation | 3.16 | |||
| Semi Deviation | 3.68 | |||
| Downside Deviation | 10.7 | |||
| Coefficient Of Variation | 843.61 | |||
| Standard Deviation | 6.62 | |||
| Variance | 43.89 | |||
| Information Ratio | 0.1072 | |||
| Jensen Alpha | 0.6702 | |||
| Total Risk Alpha | 0.1907 | |||
| Sortino Ratio | 0.0664 | |||
| Treynor Ratio | 0.4787 | |||
| Maximum Drawdown | 52.45 | |||
| Value At Risk | (4.69) | |||
| Potential Upside | 12.11 | |||
| Downside Variance | 114.55 | |||
| Semi Variance | 13.52 | |||
| Expected Short fall | (12.38) | |||
| Skewness | 1.76 | |||
| Kurtosis | 10.83 |
Ascletis Pharma Backtested Returns
Ascletis Pharma appears to be dangerous, given 3 months investment horizon. Ascletis Pharma secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of standard deviation over the last 3 months. By analyzing Ascletis Pharma's technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please makes use of Ascletis Pharma's risk adjusted performance of 0.0961, and Mean Deviation of 3.16 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ascletis Pharma holds a performance score of 9. The firm shows a Beta (market volatility) of 1.62, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ascletis Pharma will likely underperform. Please check Ascletis Pharma's sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether Ascletis Pharma's price patterns will revert.
Auto-correlation | -0.41 |
Modest reverse predictability
Ascletis Pharma has modest reverse predictability. Overlapping area represents the amount of predictability between Ascletis Pharma time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ascletis Pharma price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Ascletis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Currently Active Assets on Macroaxis
Other Information on Investing in Ascletis Pink Sheet
Ascletis Pharma financial ratios help investors to determine whether Ascletis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascletis with respect to the benefits of owning Ascletis Pharma security.